tetano
Editor, Senior Moderator
Life Sci
. 2021 Mar 24;119410.
doi: 10.1016/j.lfs.2021.119410. Online ahead of print.
Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity
Rosalinda Posadas-S?nchez[SUP] 1 [/SUP], Fausto S?nchez-Mu?oz[SUP] 2 [/SUP], Carlos Alfonso Guzm?n Martin[SUP] 2 [/SUP], Adrian Hern?ndez-D?az Couder[SUP] 2 [/SUP], Gustavo Rojas-Velasco[SUP] 3 [/SUP], Jos? Manuel Fragoso[SUP] 4 [/SUP], Gilberto Vargas-Alarc?n[SUP] 5 [/SUP]
Affiliations
Abstract
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes de COVID-19 disease use as a principal receptor the angiotensin-converting enzyme-2 (ACE2). It has been suggested that Dipeptidyl peptidase-4 (DPP4) can be another possible receptor for this virus. The present study aimed to establish if the DPP4 levels and DPP4 polymorphisms are associated with COVID-19 disease and its severity.
Methods: The study included 107 COVID-19 patients and 263 matched-healthy controls. Fifty patients required invasive mechanical ventilation. The DPP4 was quantified in serum using the Bioplex system. Based on the previous results and the functional prediction analysis, we select for the study 5 DPP4 polymorphisms (rs12617336, rs12617656, rs1558957, rs3788979, and rs17574) and these were determined using the 5?exonuclease TaqMan assays.
Results: Low levels of DPP4 were observed in COVID-19 patients (46.5 [33.1-57.7] ng/mL) when compared to healthy controls (125.3 [100.3-157.3] ng/mL) (P < 0.0001). Also, patients that required mechanical ventilation showed lower DPP4 levels (42.8 [29.8-56.9] ng/mL) than those that did not need this procedure (49.2 [39.9-65.6] ng/mL) (P = 0.012). DPP4 levels correlated negatively with age, fibrinogen, and platelet levels, and positively with albumin, alanine aminotransferase, and percentage of neutrophils. The DPP4 rs3788979 polymorphism was associated with a high risk of COVID-19 disease and, the TT genotype carriers had the lowest DPP4 levels.
Conclusions: In summary, in the present study, an association of low levels of DDP4 with COVID-19 disease and severity was found. The association of the DPP4 rs3788979 polymorphism with COVID-19 is also reported.
Keywords: Angiotensin converting enzyme-2; COVID-19 disease; Dipeptidylpeptidase-4; Polymorphisms; Severe acute respiratory syndrome coronavirus 2.
. 2021 Mar 24;119410.
doi: 10.1016/j.lfs.2021.119410. Online ahead of print.
Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity
Rosalinda Posadas-S?nchez[SUP] 1 [/SUP], Fausto S?nchez-Mu?oz[SUP] 2 [/SUP], Carlos Alfonso Guzm?n Martin[SUP] 2 [/SUP], Adrian Hern?ndez-D?az Couder[SUP] 2 [/SUP], Gustavo Rojas-Velasco[SUP] 3 [/SUP], Jos? Manuel Fragoso[SUP] 4 [/SUP], Gilberto Vargas-Alarc?n[SUP] 5 [/SUP]
Affiliations
- PMID: 33774023
- DOI: 10.1016/j.lfs.2021.119410
Abstract
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes de COVID-19 disease use as a principal receptor the angiotensin-converting enzyme-2 (ACE2). It has been suggested that Dipeptidyl peptidase-4 (DPP4) can be another possible receptor for this virus. The present study aimed to establish if the DPP4 levels and DPP4 polymorphisms are associated with COVID-19 disease and its severity.
Methods: The study included 107 COVID-19 patients and 263 matched-healthy controls. Fifty patients required invasive mechanical ventilation. The DPP4 was quantified in serum using the Bioplex system. Based on the previous results and the functional prediction analysis, we select for the study 5 DPP4 polymorphisms (rs12617336, rs12617656, rs1558957, rs3788979, and rs17574) and these were determined using the 5?exonuclease TaqMan assays.
Results: Low levels of DPP4 were observed in COVID-19 patients (46.5 [33.1-57.7] ng/mL) when compared to healthy controls (125.3 [100.3-157.3] ng/mL) (P < 0.0001). Also, patients that required mechanical ventilation showed lower DPP4 levels (42.8 [29.8-56.9] ng/mL) than those that did not need this procedure (49.2 [39.9-65.6] ng/mL) (P = 0.012). DPP4 levels correlated negatively with age, fibrinogen, and platelet levels, and positively with albumin, alanine aminotransferase, and percentage of neutrophils. The DPP4 rs3788979 polymorphism was associated with a high risk of COVID-19 disease and, the TT genotype carriers had the lowest DPP4 levels.
Conclusions: In summary, in the present study, an association of low levels of DDP4 with COVID-19 disease and severity was found. The association of the DPP4 rs3788979 polymorphism with COVID-19 is also reported.
Keywords: Angiotensin converting enzyme-2; COVID-19 disease; Dipeptidylpeptidase-4; Polymorphisms; Severe acute respiratory syndrome coronavirus 2.